Leeward Investments LLC MA Has $36.90 Million Position in Encompass Health Co. (NYSE:EHC)

Leeward Investments LLC MA lowered its holdings in Encompass Health Co. (NYSE:EHC) by 1.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 553,108 shares of the company’s stock after selling 8,893 shares during the quarter. Encompass Health makes up 1.7% of Leeward Investments LLC MA’s portfolio, making the stock its 2nd biggest position. Leeward Investments LLC MA’s holdings in Encompass Health were worth $36,903,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of EHC. International Assets Investment Management LLC bought a new position in shares of Encompass Health during the 4th quarter worth approximately $20,210,000. Sumitomo Mitsui Trust Holdings Inc. raised its stake in shares of Encompass Health by 2.3% during the 4th quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,318,784 shares of the company’s stock worth $87,989,000 after acquiring an additional 29,926 shares in the last quarter. Phocas Financial Corp. raised its stake in shares of Encompass Health by 112.4% during the 4th quarter. Phocas Financial Corp. now owns 99,875 shares of the company’s stock worth $6,664,000 after acquiring an additional 52,847 shares in the last quarter. Nordea Investment Management AB raised its stake in shares of Encompass Health by 21.0% during the 4th quarter. Nordea Investment Management AB now owns 101,705 shares of the company’s stock worth $6,787,000 after acquiring an additional 17,684 shares in the last quarter. Finally, Oak Thistle LLC raised its stake in shares of Encompass Health by 19.1% during the 4th quarter. Oak Thistle LLC now owns 14,436 shares of the company’s stock worth $963,000 after acquiring an additional 2,319 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently commented on EHC shares. Mizuho boosted their price objective on shares of Encompass Health from $93.00 to $95.00 and gave the stock a “buy” rating in a research note on Thursday. Raymond James restated a “strong-buy” rating and set a $95.00 price target (up previously from $85.00) on shares of Encompass Health in a research note on Friday. William Blair restated an “outperform” rating on shares of Encompass Health in a research note on Wednesday, February 7th. Stephens restated an “overweight” rating and set a $85.00 price target on shares of Encompass Health in a research note on Tuesday, January 16th. Finally, Truist Financial upped their price target on shares of Encompass Health from $82.00 to $86.00 and gave the company a “buy” rating in a research note on Friday, February 9th. Eight research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $86.56.

Encompass Health Stock Down 0.3 %

EHC stock opened at $82.46 on Friday. The firm’s fifty day simple moving average is $78.25 and its 200-day simple moving average is $70.87. The company has a market capitalization of $8.26 billion, a P/E ratio of 22.29, a price-to-earnings-growth ratio of 1.50 and a beta of 0.94. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.37 and a quick ratio of 1.28. Encompass Health Co. has a 12 month low of $57.55 and a 12 month high of $85.84.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Wednesday, April 24th. The company reported $1.12 EPS for the quarter, beating the consensus estimate of $0.93 by $0.19. The business had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.27 billion. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. The business’s revenue for the quarter was up 13.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.88 EPS. As a group, equities research analysts forecast that Encompass Health Co. will post 4.04 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.73%. The ex-dividend date of this dividend was Thursday, March 28th. Encompass Health’s dividend payout ratio (DPR) is presently 16.22%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.